過去ログ

                                Page  829630
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
   通常モードに戻る  ┃  INDEX  ┃  ≪前へ  │  次へ≫   
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
 ▼compensation deal .  Stypelilliops 13/10/1(火) 12:07

 ───────────────────────────────────────
 ■題名 : compensation deal .
 ■名前 : Stypelilliops <roallusualplc@autoonlineairmax.us>
 ■日付 : 13/10/1(火) 12:07
 ■Web : http://miumiudiscountsale.cha-mama.com/
 -------------------------------------------------------------------------
   3

As promised in the 2012 assessment post, we'll recap the five &#12511;&#12517;&#12454;&#12511;&#12517;&#12454; &#12496;&#12483;&#12464; &#12452;&#12456;&#12525;&#12540; person most desirable and worst performing stocks of Magic Formula Investing (MFI) in 2012, together with http://seikogenuine.tectura-fasttrack.com/ some comments on every. The idea here &#12475;&#12452;&#12467;&#12540; &#12502;&#12521;&#12452;&#12484; will be to attempt and determine any trends or lessons we can take from these individual miumiu &#12496;&#12483;&#12464; 2013 stocks and apply to selecting stocks in the screen going forward.

In this &#12511;&#12517;&#12454;&#12511;&#12517;&#12454; &#36001;&#24067; &#12496;&#12452;&#12510; continued &#20170;&#12424;&#12426;&#22810;&#12367;&#12398;&#21106;&#24341; write-up, we'll cover the five most beneficial http://seikohighquality.tectura-fasttrack.com/ performing stocks of MFI in 2012. With no additional ado.

Expedia delivered more than &#12511;&#12517;&#12454;&#12511;&#12517;&#12454; &#12496;&#12483;&#12464; &#26032;&#20316; 2013 100% gains in 2012, as travel volume boomed and Expedia continued to take share within the on the internet travel market, delivering outstanding final results for each and every quarter of the year. The provider has constantly &#12511;&#12517;&#12454;&#12511;&#12517;&#12454; &#36001;&#24067; &#12522;&#12508;&#12531; been one particular on the prime dogs (together with Priceline (PCLN)) in internet travel, a secularly increasing http://miumiuonsalejp.bikelanepaper.com/ sector. The lesson? You can easily quite often do well by choosing the lead players in expanding markets from MFI, particularly where one can find substantial barriers to entry (in this case, a network impact).

Trading in the mid$4 variety for much of your &#12511;&#12517;&#12454;&#12511;&#12517;&#12454; &#36001;&#24067; &#12496;&#12452;&#12510; first half in the &#12511;&#12517;&#12454;&#12511;&#12517;&#12454; &#36001;&#24067; &#12522;&#12508;&#12531; year, Osiris took off on several news products inside the MayJuly period exactly where it won reimbursement for its stem cell primarily based wound care matrix Grafix, together with initial approvals for Prochymal. It's not uncommon to possess http://miumiudiscountsale.bikelanepaper.com/ little, early stage pharmaceutical providers from MFI do both especially properly and very poorly just about every year. The lesson? Do not &#24112;&#12387;&#12390; be afraid to choose &#21462;&#12427; a handful of of those in the screens, but don't anticipate to become able http://miumiudiscountonline.bikelanepaper.com/ to help keep &#32972;&#12364;&#39640;&#12367; to predict how they're going to do, either!

Cray had an unbelievable year. The provider sold its interconnect small business &#12511;&#12517;&#12454;&#12511;&#12517;&#12454; &#12496;&#12483;&#12464; &#26032;&#20316; 2013 market place miumiu &#36001;&#24067; &#20844;&#24335; to Intel (INTC), netting $140 million in money (more than half the firm's market place http://miumiuselljp.bikelanepaper.com/ cap at the time!) plus a closer relationship miumiu &#36001;&#24067; &#12496;&#12452;&#12510; using a key miumiu &#12463;&#12521;&#12483;&#12481;&#12496;&#12483;&#12464; partner. Then a steady stream of bargains culminated within the acquisition of Appro, a crucial competitor, in November. The lesson? Cray has generally been a leader inside a rather niche marketplace where competition is limited and barriers to entry are significant. This is a nice profile to appear for in MFI stocks.

Trading in the higher $1 variety for most of the year, Acadia's rise is on account of a single event:productive Phase III final results from their lead Parkinson's drug, Pimavanserin, which more than doubled the stock price on November 27. This was a rather unexpected development &#32972;&#12364;&#39640;&#12367; (see our writeup via the above link), however the lesson here is comparable to Osiris do not be afraid to carry a couple of devstage pharmaceuticals, but if you are going to choose them, choose a number of and maintain miumiu &#12496;&#12483;&#12464; &#12475;&#12540;&#12523; person positions pretty small.
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━    通常モードに戻る  ┃  INDEX  ┃  ≪前へ  │  次へ≫    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━                                 Page 829630